Sofosbuvir And Velpatasvir Tablet, Film Coated
Product Images NDC 72626-2701

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Sofosbuvir And Velpatasvir (NDC 72626-2701). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asegua Therapeutics Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Sofosbuvir 01)

Chemical structure of velpatasvir and sofosbuvir, the active ingredients in the Sofosbuvir and Velpatasvir oral film-coated tablet by Asegua Therapeutics LLC.*

FDA Label Image

Chemical Structure (Sofosbuvir 02)

Chemical structure of Sofosbuvir and Velpatasvir, the active ingredients in this prescription drug by Asegua Therapeutics LLC. The diagram shows the detailed molecular formula indicating the arrangement of atoms and bonds in the compound.*

FDA Label Image

Principal Display Panel (14 Tablet Blister Card Carton)

Packaging label for Sofosbuvir and Velpatasvir 400 mg / 100 mg tablets by Asegua Therapeutics LLC. The label shows the product name, strength, and dosage form, indicating it is a prescription oral film-coated tablet. The carton contains 28 tablets in two blister cards with 14 tablets each. It is noted as an authorized generic of Epclusa, with manufacturing information and storage instructions included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.